EXPANDABLE MEMBER DISSECTION PORT
    64.
    发明申请
    EXPANDABLE MEMBER DISSECTION PORT 审中-公开
    可扩展会员离港

    公开(公告)号:US20110160539A1

    公开(公告)日:2011-06-30

    申请号:US12979628

    申请日:2010-12-28

    IPC分类号: A61B1/32

    摘要: Embodiments of the invention include a device to provide working access to a surgical site in a patient. The device may include a port component including an elongate member configured to pass through an opening in the patient. The elongate member may include a bore extending between a distal end and a proximal end of the elongate member. The port component may also include an expandable member disposed on the elongate member that may perform dissection and may form a seal to maintain insufflation pressure in a working space. The device may also include an insert component configured to be removably received inside the bore in the elongate member of the port component. The insert component may include at least one lumen that may removably receive at least one working instrument.

    摘要翻译: 本发明的实施例包括提供对患者的外科手术部位的工作访问的装置。 该装置可以包括端口部件,该端口部件包括构造成穿过患者中的开口的细长部件。 细长构件可以包括在细长构件的远端和近端之间延伸的孔。 端口部件还可以包括设置在细长构件上的可执行解剖的可膨胀构件,并且可以形成密封以维持工作空间中的吹入压力。 该装置还可以包括被配置为可移除地容纳在端口部件的细长构件中的孔内的插入部件。 插入部件可以包括至少一个可移除地容纳至少一个工作器械的内腔。

    Substituted cyclo or bicycloalkylamides of (8.beta.)-6-(substituted)
ergolines
    65.
    发明授权
    Substituted cyclo or bicycloalkylamides of (8.beta.)-6-(substituted) ergolines 失效
    (8β)-6-(取代的)麦角碱的取代的环或二环烷基酰胺

    公开(公告)号:US5441961A

    公开(公告)日:1995-08-15

    申请号:US936684

    申请日:1992-08-27

    CPC分类号: C07D457/06

    摘要: The present invention provides (8.beta.)-N-substituted cyclo or bicycloalkyl-6-(substituted)-ergoline-8-carboxamides useful for occupying 5HT.sub.2 or 5HT.sub.1c receptors in mammals. The invention also provides methods for treating a variety of disorders and conditions related to or affecting these receptors as well as pharmaceutical formulations of the compounds of the invention.

    摘要翻译: 本发明提供了可用于占据哺乳动物中5HT2或5HT1c受体的(8β)-N-取代的环或双环烷基-6-(取代的) - 麦角灵-8-甲酰胺。 本发明还提供了治疗与这些受体有关或影响这些受体的多种病症和病症的方法以及本发明化合物的药物制剂。

    3-phenyloxy-3-phenyl propanamines
    70.
    发明授权
    3-phenyloxy-3-phenyl propanamines 失效
    3-苯氧基-3-苯基丙胺

    公开(公告)号:US5238959A

    公开(公告)日:1993-08-24

    申请号:US871616

    申请日:1992-04-20

    摘要: The present invention provides 3-(4-substitutedphenoxy)-3-phenyl propanamines capable of inhibiting the uptake of serotonin. These compounds are useful for treating many pharmacological disorders, including depression and obesity. These compounds can also be used to reduce the desire to smoke and consume alcohol.

    摘要翻译: 本发明提供能够抑制5-羟色胺摄取的3-(4-取代苯氧基)-3-苯基丙胺。 这些化合物可用于治疗许多药理学障碍,包括抑郁症和肥胖症。 这些化合物也可用于减少吸烟和饮用酒精的欲望。